Related references
Note: Only part of the references are listed.Advances in the field of intranasal oxytocin research: lessons learned and future directions for clinical research
Daniel S. Quintana et al.
MOLECULAR PSYCHIATRY (2021)
Problematic presentation and use of efficacy measures in current trials of CGRP monoclonal antibodies for episodic migraine prevention: A mini-review
Peer Tfelt-Hansen et al.
CEPHALALGIA (2020)
Dihydroergotamine (DHE) - Then and Now: A Narrative Review
Stephen D. Silberstein et al.
HEADACHE (2020)
Efficacy and safety of calcitonin-gene-related peptide binding monoclonal antibodies for the preventive treatment of episodic migraine - an updated systematic review and meta-analysis
Hong Deng et al.
BMC NEUROLOGY (2020)
Cellular distribution of PACAP-38 and PACAP receptors in the rat brain: Relation to migraine activated regions
Karin Warfvinge et al.
CEPHALALGIA (2020)
Fluorescently-labeled fremanezumab is distributed to sensory and autonomic ganglia and the dura but not to the brain of rats with uncompromised blood brain barrier
Rodrigo Noseda et al.
CEPHALALGIA (2020)
Inhibition of nociceptive dural input to the trigeminocervical complex through oxytocinergic transmission
Enrique Garcia-Boll et al.
EXPERIMENTAL NEUROLOGY (2020)
Ubrogepant for the treatment of migraine
Martina Curto et al.
EXPERT OPINION ON PHARMACOTHERAPY (2020)
Lasmiditan inhibits calcitonin gene-related peptide release in the rodent trigeminovascular system
Alejandro Labastida-Ramirez et al.
PAIN (2020)
A Nonpeptide Oxytocin Receptor Agonist for a Durable Relief of Inflammatory Pain
Louis Hilfiger et al.
SCIENTIFIC REPORTS (2020)
Targeting CGRP for migraine treatment: mechanisms, antibodies, small molecules, perspectives
Eleonora De Matteis et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2020)
The Chronic Migraine Brain: What Have We Learned From Neuroimaging?
Massimo Filippi et al.
FRONTIERS IN NEUROLOGY (2020)
Real-life data on the efficacy and safety of erenumab in the Abruzzo region, central Italy
Raffaele Ornello et al.
JOURNAL OF HEADACHE AND PAIN (2020)
Imaging the Premonitory Phase of Migraine
Nazia Karsan et al.
FRONTIERS IN NEUROLOGY (2020)
The locus of action of CGRPergic monoclonal antibodies against migraine: peripheral over central mechanisms
Abimael González-Hernández et al.
CNS & Neurological Disorders-Drug Targets (2020)
Two-hour infusion of vasoactive intestinal polypeptide induces delayed headache and extracranial vasodilation in healthy volunteers
Lanfranco Pellesi et al.
CEPHALALGIA (2020)
Oxytocin as a regulatory neuropeptide in the trigeminovascular system: Localization, expression and function of oxytocin and oxytocin receptors
Karin Warfvinge et al.
CEPHALALGIA (2020)
The Rostral Agranular Insular Cortex, a New Site of Oxytocin to Induce Antinociception
Mohammed Gamal-Eltrabily et al.
JOURNAL OF NEUROSCIENCE (2020)
Differential medication overuse risk of novel anti-migraine therapeutics
Chonlawan Saengjaroentham et al.
BRAIN (2020)
Oxytocin prevents neuronal network pain-related changes on spinal cord dorsal horn in vitro
Irma A. Tello-Garcia et al.
CELL CALCIUM (2020)
Activation orexin 1 receptors in the ventrolateral periaqueductal gray matter attenuate nitroglycerin-induced migraine attacks and calcitonin gene related peptide up-regulation in trigeminal nucleus caudalis of rats
Razieh Kooshki et al.
NEUROPHARMACOLOGY (2020)
Pharmacological treatment of migraine: CGRP and 5-HT beyond the triptans
Tessa de Vries et al.
PHARMACOLOGY & THERAPEUTICS (2020)
Monoclonal antibodies blocking CGRP transmission: An update on their added value in migraine prevention
J. Schoenen et al.
REVUE NEUROLOGIQUE (2020)
CGRP inhibitors for migraine prophylaxis: a safety review
Eduardo Rivera-Mancilla et al.
EXPERT OPINION ON DRUG SAFETY (2020)
Targeting pituitary adenylate cyclase-activating polypeptide (PACAP) with monoclonal antibodies in migraine prevention: a brief review
Cecilia Rustichelli et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2020)
Conversion from chronic to episodic migraine in patients treated with erenumab: real-life data from an Italian region
Raffaele Ornello et al.
JOURNAL OF HEADACHE AND PAIN (2020)
Improvements across a range of patient-reported domains with fremanezumab treatment: results from a patient survey study
Dawn C. Buse et al.
JOURNAL OF HEADACHE AND PAIN (2020)
Atogepant Calcitonin gene-related peptide (CGRP) receptor antagonist Preventive treatment of migraine
P. Martelletti et al.
DRUGS OF THE FUTURE (2020)
Peripheral oxytocin restores light touch and nociceptor sensory afferents towards normal after nerve injury
M. Danilo Boada et al.
PAIN (2019)
Phase 3 randomized, placebo-controlled, double-blind study of lasmiditan for acute treatment of migraine
Peter J. Goadsby et al.
BRAIN (2019)
Effect of local infiltration with oxytocin on hemodynamic response to surgical incision and postoperative pain in patients having open laparoscopic surgery under general anesthesia
Hector Zayas-Gonzalez et al.
EUROPEAN JOURNAL OF PAIN (2019)
Gepants for the treatment of migraine
Andrea Negro et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2019)
CGRP and the Trigeminal System in Migraine
Smriti Iyengar et al.
HEADACHE (2019)
Erenumab in chronic migraine with medication overuse Subgroup analysis of a randomized trial
Stewart J. Tepper et al.
NEUROLOGY (2019)
Emerging Treatment Targets for Migraine and Other Headaches
Zachariah Bertels et al.
HEADACHE (2019)
Characterization of binding, functional activity, and contractile responses of the selective 5-HT1F receptor agonist lasmiditan
Eloisa Rubio-Beltran et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
Discontinuation of Acute Prescription Medication for Migraine: Results From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study
Richard B. Lipton et al.
HEADACHE (2019)
Novel Medications for the Treatment of Migraine
Claire E. J. Ceriani et al.
HEADACHE (2019)
Animal models of migraine and experimental techniques used to examine trigeminal sensory processing
Andrea M. Harriott et al.
JOURNAL OF HEADACHE AND PAIN (2019)
Migraine and the trigeminovascular system-40 years and counting
Messoud Ashina et al.
LANCET NEUROLOGY (2019)
Recurrent antinociception induced by intrathecal or peripheral oxytocin in a neuropathic pain rat model
Abimael Gonzalez-Hernandez et al.
EXPERIMENTAL BRAIN RESEARCH (2019)
Monoclonal antibodies for the prevention of migraine
Bianca Raffaelli et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2019)
PAC1 receptor mRNA and protein distribution in rat and human trigeminal and sphenopalatine ganglia, spinal trigeminal nucleus and in dura mater
Kelly Hensley et al.
CEPHALALGIA (2019)
The Emperor's New Gepants: Are the Effects of the New Oral CGRP Antagonists Clinically Meaningful?
Peer Tfelt-Hansen et al.
HEADACHE (2019)
European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention
Simona Sacco et al.
JOURNAL OF HEADACHE AND PAIN (2019)
Pharmacologic Characterization of ALD1910, a Potent Humanized Monoclonal Antibody against the Pituitary Adenylate Cyclase-Activating Peptide
Cristina Moldovan Loomis et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2019)
Misdiagnosis of multiple sclerosis
Wallace J. Brownlee
NEUROLOGY (2019)
Side effects associated with current and prospective antimigraine pharmacotherapies
Abimael Gonzalez-Hernandez et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2018)
Oxytocin and Pain Perception: From Animal Models to Human Research
S. Boll et al.
NEUROSCIENCE (2018)
ARISE: A Phase 3 randomized trial of erenumab for episodic migraine
David W. Dodick et al.
CEPHALALGIA (2018)
Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition
Jes Olesen
CEPHALALGIA (2018)
Saliva oxytocin measures do not reflect peripheral plasma concentrations after intranasal oxytocin administration in men
Daniel S. Quintana et al.
HORMONES AND BEHAVIOR (2018)
Oxytocin inhibits the rat medullary dorsal horn Sp5c/C1 nociceptive transmission through OT but not VIA receptors
Enrique Garcia-Boll et al.
NEUROPHARMACOLOGY (2018)
Targeted Orexin and Hypothalamic Neuropeptides for Migraine
Lauren C. Strother et al.
NEUROTHERAPEUTICS (2018)
THE OXYTOCIN RECEPTOR: FROM INTRACELLULAR SIGNALING TO BEHAVIOR
Benjamin Jurek et al.
PHYSIOLOGICAL REVIEWS (2018)
No side-effects of single intranasal oxytocin administration in middle childhood
Martine W. F. T. Verhees et al.
PSYCHOPHARMACOLOGY (2018)
Evaluation of Galcanezumab for the Prevention of Episodic Migraine The EVOLVE-1 Randomized Clinical Trial
Virginia L. Stauffer et al.
JAMA NEUROLOGY (2018)
LIT-001, the First Nonpeptide Oxytocin Receptor Agonist that Improves Social Interaction in a Mouse Model of Autism
Marie-Celine Frantz et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Interplay between Oxytocin and Sensory Systems in the Orchestration of Socio-Emotional Behaviors
Valery Grinevich et al.
NEURON (2018)
Emerging drugs for migraine treatment: an update
Giorgio Lambru et al.
EXPERT OPINION ON EMERGING DRUGS (2018)
Oxytocin, GABA, and TRPV1, the Analgesic Triad?
Abimael Gonzalez-Hernandez et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2018)
Selective localization of oxytocin receptors and vasopressin 1a receptors in the human brainstem
Sara M. Freeman et al.
SOCIAL NEUROSCIENCE (2017)
Medication Overuse Headache: Pathophysiological Insights from Structural and Functional Brain MRI Research
Todd J. Schwedt et al.
HEADACHE (2017)
Blocking CGRP in migraine patients - a review of pros and cons
Marie Deen et al.
JOURNAL OF HEADACHE AND PAIN (2017)
The Role of 5-Hydroxytryptamine in the Pathophysiology of Migraine and its Relevance to the Design of Novel Treatments
Carlos M. Villalon et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2017)
Understanding migraine as a cycling brain syndrome: reviewing the evidence from functional imaging
Arne May
NEUROLOGICAL SCIENCES (2017)
Hypothalamus as a mediator of chronic migraine Evidence from high-resolution fMRI
Laura H. Schulte et al.
NEUROLOGY (2017)
Serotonergic mechanisms of trigeminal meningeal nociception: Implications for migraine pain
Erkan Kilinc et al.
NEUROPHARMACOLOGY (2017)
A Controlled Trial of Erenumab for Episodic Migraine
Peter J. Goadsby et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Oxytocin alleviates orofacial mechanical hypersensitivity associated with infraorbital nerve injury through vasopressin-1A receptors of the rat trigeminal ganglia
Asako Kubo et al.
PAIN (2017)
PATHOPHYSIOLOGY OF MIGRAINE: A DISORDER OF SENSORY PROCESSING
Peter J. Goadsby et al.
PHYSIOLOGICAL REVIEWS (2017)
Spotlight on Anti-CGRP Monoclonal Antibodies in Migraine: The Clinical Evidence to Date
Lanfranco Pellesi et al.
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT (2017)
Of generators, networks and migraine attacks
Laura H. Schulte et al.
CURRENT OPINION IN NEUROLOGY (2017)
A review of the role of orexin system in pain modulation
Bibi Marjan Razavi et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Change in brain network connectivity during PACAP38-induced migraine attacks A resting-state functional MRI study
Faisal Mohammad Amin et al.
NEUROLOGY (2016)
Oxytocin in General Anxiety and Social Fear: A Translational Approach
Inga D. Neumann et al.
BIOLOGICAL PSYCHIATRY (2016)
The migraine generator revisited: continuous scanning of the migraine cycle over 30 days and three spontaneous attacks
Laura H. Schulte et al.
BRAIN (2016)
Premonitory symptoms in migraine: A cross-sectional study in 2714 persons
Katarina Laurell et al.
CEPHALALGIA (2016)
Oxytocin receptor: Expression in the trigeminal nociceptive system and potential role in the treatment of headache disorders
Alexander Tzabazis et al.
CEPHALALGIA (2016)
Successful Pain Management with Epidural Oxytocin
Miguel Condes-Lara et al.
CNS NEUROSCIENCE & THERAPEUTICS (2016)
The migraine postdrome
Pyari Bose et al.
CURRENT OPINION IN NEUROLOGY (2016)
Network meta-analysis of migraine disorder treatment by NSAIDs and triptans
Haiyang Xu et al.
JOURNAL OF HEADACHE AND PAIN (2016)
Triptans disrupt brain networks and promote stress-induced CSD-like responses in cortical and subcortical areas
L. Becerra et al.
JOURNAL OF NEUROPHYSIOLOGY (2016)
Safety and efficacy of AMG 334 for prevention of episodic migraine: a randomised, double-blind, placebo-controlled, phase 2 trial
Hong Sun et al.
LANCET NEUROLOGY (2016)
The migraine postdrome An electronic diary study
Nicola J. Giffin et al.
NEUROLOGY (2016)
A New Population of Parvocellular Oxytocin Neurons Controlling Magnocellular Neuron Activity and Inflammatory Pain Processing
Marina Eliava et al.
NEURON (2016)
NEUROVASCULAR CONTRIBUTIONS TO MIGRAINE: MOVING BEYOND VASODILATION
Blaine Jacobs et al.
NEUROSCIENCE (2016)
Wiping Out CGRP: Potential Cardiovascular Risks
Antoinette MaassenVanDenBrink et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2016)
Heteroreceptors Modulating CGRP Release at Neurovascular Junction: Potential Therapeutic Implications on Some Vascular-Related Diseases
Abimael Gonzalez-Hernandez et al.
BIOMED RESEARCH INTERNATIONAL (2016)
Evidence for Non-Linear Pharmacokinetics of Oxytocin in Anesthetizetized Rat
Eric Troncy et al.
JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES (2016)
Pharmacologic Characterization of AMG 334, a Potent and Selective Human Monoclonal Antibody against the Calcitonin Gene-Related Peptide Receptor
Licheng Shi et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2016)
Phase 1 Safety Assessment of Intrathecal Oxytocin
James C. Eisenach et al.
ANESTHESIOLOGY (2015)
Migraine: Multiple Processes, Complex Pathophysiology
Rami Burstein et al.
JOURNAL OF NEUROSCIENCE (2015)
Evidence for orexinergic mechanisms in migraine
Jan Hoffmann et al.
NEUROBIOLOGY OF DISEASE (2015)
Neuronal PAC1 receptors mediate delayed activation and sensitization of trigeminocervical neurons: Relevance to migraine
Simon Akerman et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Investigation of the pathophysiological mechanisms of migraine attacks induced by pituitary adenylate cyclase-activating polypeptide-38
Faisal Mohammad Amin et al.
BRAIN (2014)
BMS-927711 for the acute treatment of migraine: A double-blind, randomized, placebo controlled, dose-ranging trial
Ronald Marcus et al.
CEPHALALGIA (2014)
Oxytocin and Pain A Systematic Review and Synthesis of Findings
Joshua A. Rash et al.
CLINICAL JOURNAL OF PAIN (2014)
The Multitarget Drug Approach in Migraine Treatment: The New Challenge to Conquer
Abimael Gonzalez-Hernandez et al.
HEADACHE (2014)
Identifying the Factors Underlying Discontinuation of Triptans
Rebecca E. Wells et al.
HEADACHE (2014)
Treatment Persistence and Switching in Triptan Users: A Systematic Literature Review
Andrew J. Messali et al.
HEADACHE (2014)
An Ongoing Role of α-Calcitonin Gene-Related Peptide as Part of a Protective Network Against Hypertension, Vascular Hypertrophy, and Oxidative Stress
Sarah-Jane Smillie et al.
HYPERTENSION (2014)
Safety and efficacy of ALD403, an antibody to calcitonin gene-related peptide, for the prevention of frequent episodic migraine: a randomised, double-blind, placebo-controlled, exploratory phase 2 trial
David W. Dodick et al.
LANCET NEUROLOGY (2014)
PACAP-38 but not VIP induces release of CGRP from trigeminal nucleus caudalis via a receptor distinct from the PAC1 receptor
Inger Jansen-Olesen et al.
NEUROPEPTIDES (2014)
Parabrachial nucleus (PBn) pituitary adenylate cyclase activating polypeptide (PACAP) signaling in the amygdala: Implication for the sensory and behavioral effects of pain
Galen Missig et al.
NEUROPHARMACOLOGY (2014)
CALCITONIN GENE-RELATED PEPTIDE: PHYSIOLOGY AND PATHOPHYSIOLOGY
F. A. Russell et al.
PHYSIOLOGICAL REVIEWS (2014)
Oxytocin and analgesia: future trends
Abimael Gonzalez-Hernandez et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2014)
Pituitary adenylate cyclase activating polypeptide and migraine
Alessandro S. Zagami et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2014)
Frequency and Burden of Headache-Related Nausea: Results From the American Migraine Prevalence and Prevention (AMPP) Study
Richard B. Lipton et al.
HEADACHE (2013)
Paraventricular Hypothalamic Regulation of Trigeminovascular Mechanisms Involved in Headaches
Claude Robert et al.
JOURNAL OF NEUROSCIENCE (2013)
The interaction between the oxytocin and pain modulation in headache patients
Yong-Liang Wang et al.
NEUROPEPTIDES (2013)
Bilateral Descending Hypothalamic Projections to the Spinal Trigeminal Nucleus Caudalis in Rats
Khaled Abdallah et al.
PLOS ONE (2013)
In Vivo Quantification of Calcitonin Gene-Related Peptide Receptor Occupancy by Telcagepant in Rhesus Monkey and Human Brain Using the Positron Emission Tomography Tracer [11C]MK-4232
Eric D. Hostetler et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2013)
Role of 5-HT1 receptor subtypes in the modulation of pain and synaptic transmission in rat spinal superficial dorsal horn
Hyo-Jin Jeong et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Pharmacological evidence that spinal α2C- and, to a lesser extent, α2A-adrenoceptors inhibit capsaicin-induced vasodilatation in the canine external carotid circulation
Carlos M. Villalon et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2012)
Intrathecal dihydroergotamine inhibits capsaicin-induced vasodilatation in the canine external carotid circulation via GR127935- and rauwolscine-sensitive receptors
Bruno A. Marichal-Cancino et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2012)
Factors Associated With Triptan Use in Episodic Migraine: Results From the American Migraine Prevalence and Prevention Study
Min Kyung Chu et al.
HEADACHE (2012)
Dihydroergotamine, Ergotamine, Methysergide and Sumatriptan - Basic Science in Relation to Migraine Treatment
Carl Dahlof et al.
HEADACHE (2012)
Functional Selective Oxytocin-derived Agonists Discriminate between Individual G Protein Family Subtypes
Marta Busnelli et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Efficacy and tolerability of lasmiditan, an oral 5-HT1F receptor agonist, for the acute treatment of migraine: a phase 2 randomised, placebo-controlled, parallel-group, dose-ranging study
Markus Farkkila et al.
LANCET NEUROLOGY (2012)
Neuropeptide Transmission in Brain Circuits
Anthony N. van den Pol
NEURON (2012)
DISTRIBUTION OF VASOACTIVE INTESTINAL PEPTIDE, PITUITARY ADENYLATE CYCLASE-ACTIVATING PEPTIDE, NITRIC OXIDE SYNTHASE, AND THEIR RECEPTORS IN HUMAN AND RAT SPHENOPALATINE GANGLION
A. Csati et al.
NEUROSCIENCE (2012)
Peripheral and central alterations of pituitary adenylate cyclase activating polypeptide-like immunoreactivity in the rat in response to activation of the trigeminovascular system
Bernadett Tuka et al.
PEPTIDES (2012)
Basic mechanisms of migraine and its acute treatment
Lars Edvinsson et al.
PHARMACOLOGY & THERAPEUTICS (2012)
Adherence with Migraine Prophylaxis in Clinical Practice
Ariel Berger et al.
PAIN PRACTICE (2012)
Pharmacological characterization of VIP and PACAP receptors in the human meningeal and coronary artery
Kayi Y. Chan et al.
CEPHALALGIA (2011)
Chemical Mediators of Migraine: Preclinical and Clinical Observations
Saurabh Gupta et al.
HEADACHE (2011)
The Extracranial Vascular Theory of Migraine-A Great Story Confirmed by the Facts
Elliot Shevel
HEADACHE (2011)
Diencephalic and brainstem mechanisms in migraine
Simon Akerman et al.
NATURE REVIEWS NEUROSCIENCE (2011)
Potential mechanisms of prospective antimigraine drugs: A focus on vascular (side) effects
Kayi Y. Chan et al.
PHARMACOLOGY & THERAPEUTICS (2011)
A review of safety, side-effects and subjective reactions to intranasal oxytocin in human research
Elayne MacDonald et al.
PSYCHONEUROENDOCRINOLOGY (2011)
Acute treatment of migraine with the selective 5-HTIF receptor agonist lasmiditan - A randomised proof-of-concept trial
Michel D. Ferrari et al.
CEPHALALGIA (2010)
Calcitonin gene-related peptide triggers migraine-like attacks in patients with migraine with aura
Jakob Moller Hansen et al.
CEPHALALGIA (2010)
Cutaneous nociception and neurogenic inflammation evoked by PACAP38 and VIP
Henrik Winther Schytz et al.
JOURNAL OF HEADACHE AND PAIN (2010)
The relevance of preclinical research models for the development of antimigraine drugs: Focus on 5-HT1B/1D and CGRP receptors
Saurabh Gupta et al.
PHARMACOLOGY & THERAPEUTICS (2010)
PACAP38 induces migraine-like attacks in patients with migraine without aura
Henrik Winther Schytz et al.
BRAIN (2009)
The vascular theory of migrainea great story wrecked by the facts
Peter J. Goadsby
BRAIN (2009)
Orexin/Hypocretin: A Neuropeptide at the Interface of Sleep, Energy Homeostasis, and Reward System
N. Tsujino et al.
PHARMACOLOGICAL REVIEWS (2009)
The role of CGRP in the pathophysiology of migraine and efficacy of CGRP receptor antagonists as acute antimigraine drugs
Carlos M. Villalon et al.
PHARMACOLOGY & THERAPEUTICS (2009)
VPAC and PAC receptors: From ligands to function
Louise Dickson et al.
PHARMACOLOGY & THERAPEUTICS (2009)
Involvement of corticotrophin-releasing factor and orexin-A in chronic migraine and medication-overuse headache: findings from cerebrospinal fluid
P. Sarchielli et al.
CEPHALALGIA (2008)
Paraventricular hypothalamic nucleus stimulation modulates nociceptive responses in dorsal horn wide dynamic range neurons
Miguel Condes-Lara et al.
NEUROSCIENCE LETTERS (2008)
PVN electrical stimulation prolongs withdrawal latencies and releases oxytocin in cerebrospinal fluid, plasma, and spinal cord tissue in intact and neuropathic rats
Guadalupe Martinez-Lorenzan et al.
PAIN (2008)
International Union of Pharmacology. LXIX. Status of the calcitonin gene-related peptide subtype 2 receptor
Debbie L. Hay et al.
PHARMACOLOGICAL REVIEWS (2008)
Frovatriptan review
Farkkila Markus et al.
EXPERT OPINION ON PHARMACOTHERAPY (2007)
Cardiovascular responses produced by 5-hydroxytriptamine: a pharmacological update on the receptors/mechanisms involved and therapeutic implications
Carlos M. Villalon et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2007)
Insomnia and circadian variation of attacks in episodic migraine
Karl Alstadhaug et al.
HEADACHE (2007)
The hypothalamic orexinergic system: Pain and primary headaches
Philip Holland et al.
HEADACHE (2007)
The neural circuit of orexin (hypocretin): maintaining sleep and wakefulness
Takeshi Sakurai
NATURE REVIEWS NEUROSCIENCE (2007)
Modulation of nociceptive dural input to the trigeminal nucleus caudalis via activation of the orexin 1 receptor in the rat
P. R. Holland et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2006)
The prevalence of premonitory symptoms in migraine: a questionnaire study in 461 patients
G. G. Schoonman et al.
CEPHALALGIA (2006)
Premonitory and resolution symptoms in migraine:: a prospective study in 100 unselected patients
E. Quintela et al.
CEPHALALGIA (2006)
Paraventricular hypothalamic influences on spinal nociceptive processing
M Condés-Lara et al.
BRAIN RESEARCH (2006)
Orexins in the regulation of the hypothalamic-pituitary-adrenal axis
R Spinazzi et al.
PHARMACOLOGICAL REVIEWS (2006)
Experimental migraine models and their relevance in migraine therapy
U Arulmani et al.
CEPHALALGIA (2006)
Location and function of VPAC(1), VPAC(2) and NPR-C receptors in VIP-induced vasodilation of porcine basilar arteries
S Grant et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2006)
Orexin 1 receptor activation attenuates neurogenic dural vasodilation in an animal model of trigeminovascular nociception
PR Holland et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Neurogenic inflammation and migraine: Implications for therapeutics
SJ Peroutka
MOLECULAR INTERVENTIONS (2005)
Oxytocin actions on afferent evoked spinal cord neuronal activities in neuropathic but not in normal rats
M Condés-Lara et al.
BRAIN RESEARCH (2005)
Sumatriptan causes parallel decrease in plasma calcitonin gene-related peptide (CGRP) concentration and migraine headache during nitroglycerin induced migraine attack
G Juhasz et al.
CEPHALALGIA (2005)
Calcitonin gene-related peptide and its role in migraine pathophysiology
U Arulmani et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2004)
Activation of 5-HT1B/1D receptor in the periaqueductal gray inhibits nociception
T Bartsch et al.
ANNALS OF NEUROLOGY (2004)
Vascular actions of calcitonin gene-related peptide and adrenomedullin
SD Brain et al.
PHYSIOLOGICAL REVIEWS (2004)
Frovatriptan succinate, a 5-HT1B/1D receptor agonist for migraine
EA Balbisi
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2004)
Differential modulation of nociceptive dural input to [hypocretin] orexin A and B receptor activation in the posterior hypothalamic area
T Bartsch et al.
PAIN (2004)
NO-induced migraine attack: strong increase in plasma calcitonin gene-related peptide (CGRP) concentration and negative correlation with platelet serotonin release
G Juhasz et al.
PAIN (2003)
Antiallodynic effects of intrathecal orexins in a rat model of postoperative pain
JK Cheng et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Ergotamine and dihydroergotamine: History, pharmacology, and efficacy
SD Silberstein et al.
HEADACHE (2003)
Morphine withdrawal is modified in pituitary adenylate cyclase-activating polypeptide type I-receptor-deficient mice
M Martin et al.
MOLECULAR BRAIN RESEARCH (2003)
Functions of the orexinergic/hypocretinergic system
JP Kukkonen et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2002)
Triptans (serotonin, 5-HT1B/1D agonists) in migraine:: detailed results and methods of a meta-analysis of 53 trials
MD Ferrari et al.
CEPHALALGIA (2002)
Analgesic effect of intrathecally administered orexin-A in the rat formalin test in the rat hot plate test
T Yamamoto et al.
BRITISH JOURNAL OF PHARMACOLOGY (2002)
International Union of Pharmacology. XXXII. The mammalian calcitonin gene-related peptides, adrenomedullin, amylin, and calcitonin receptors
DR Poyner et al.
PHARMACOLOGICAL REVIEWS (2002)
Distribution of mRNA for VIP and PACAP receptors in human cerebral arteries and cranial ganglia
M Knutsson et al.
NEUROREPORT (2002)
CGRP may play a causative role in migraine
LH Lassen et al.
CEPHALALGIA (2002)
Neuropeptide expression in the human trigeminal nucleus caudalis and in the cervical spinal cord C1 and C2
R Uddman et al.
CEPHALALGIA (2002)
Hypothalamic involvement in chronic migraine
MFP Peres et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2001)
The role of the CGRP-receptor component protein (RCP) in adrenomedullin receptor signal transduction
MA Prado et al.
PEPTIDES (2001)
Brainstem activation specific to migraine headache
A Bahra et al.
LANCET (2001)
Triptans in migraine - A comparative review of pharmacology, pharmacokinetics and efficacy
P Tfelt-Hansen et al.
DRUGS (2000)
Trigeminohypothalamic and reticulohypothalamic tract neurons in the upper cervical spinal cord and caudal medulla of the rat
A Malick et al.
JOURNAL OF NEUROPHYSIOLOGY (2000)
Migraine -: The evolution of our knowledge
A Rapoport et al.
ARCHIVES OF NEUROLOGY (2000)
Distribution of orexin-A and orexin-B (hypocretins) in the rat spinal cord
Y Date et al.
NEUROSCIENCE LETTERS (2000)
Share Paper
